Meet over 50 Experts and Innovators shaping Brain Health & Enhancement

Confirmed Summit Speakers, Chairs and Judges


Dr. Adam Gazzaley, Professor of Neurology and Founding Director of Neuroscape at UCSF

Dr. Gaz­za­ley is a fac­ul­ty mem­ber in the Neu­rol­o­gy, Phys­i­ol­o­gy and Psy­chi­a­try depart­ments, and Direc­tor of a cog­ni­tive neu­ro­science lab­o­ra­to­ry con­duct­ing research on the neur­al mech­a­nisms of atten­tion and mem­o­ry. Dr. Gaz­za­ley is also co-founder and Chief Sci­ence Advi­sor of Akili Inter­ac­tive Labs, a com­pa­ny devel­op­ing ther­a­peu­tic video games, and co-founder and Chief Sci­en­tist of JAZZ Ven­ture Part­ners, a ven­ture cap­i­tal firm invest­ing in expe­ri­en­tial tech­nol­o­gy to improve human per­for­mance. He has received many awards and hon­ors for his research, includ­ing the 1997 Cor­ti­cal Schol­ar Award, Pfizer/AFAR Inno­va­tions in Aging Award and the Elli­son Foun­da­tion New Schol­ar Award in Aging.

Dr. Adam Haim, Chief of the Clinical Trials Operations and Biostatistics Branch at the NIMH

Dr. Haim over­sees the Small Busi­ness Inno­va­tion Research (SBIR) and Small Busi­ness Tech­nol­o­gy Trans­fer (STTR) Pro­grams at the Nation­al Insti­tute of Men­tal Health (NIMH). Both pro­grams help small busi­ness­es fund R&D with strong poten­tial for tech­nol­o­gy com­mer­cial­iza­tion, and a sig­nif­i­cant por­tion of their cur­rent grant port­fo­lio is focused on the devel­op­ment and eval­u­a­tion of mHealth inter­ven­tions and dig­i­tal health tech­nol­o­gy. Pre­vi­ous­ly, Adam was a Senior Research Fel­low at KAI Research and a post doc research fel­low at the NIMH, and com­plet­ed a res­i­den­cy at Bal­ti­more VA Med­ical Center.

Dr. Albert Kwon, Co-Founder & CEO of AUGMENTx

Dr. Albert Kwon, is an MIT and Har­vard trained biol­o­gist, pedi­a­tri­cian, and anes­the­si­ol­o­gist. After com­plet­ing his res­i­den­cies at Brigham and Wom­en’s Hos­pi­tal and Boston Chil­dren’s Hos­pi­tal, he will fur­ther spe­cial­ize in pain med­i­cine at Stan­ford. He has exten­sive basic sci­ence and engi­neer­ing research expe­ri­ence in drug deliv­ery, tis­sue engi­neer­ing and regen­er­a­tive med­i­cine with pio­neer­ing researchers at MIT and Har­vard. He is the CEO and Med­ical Direc­tor of AUGMENTx.

Alexandra Morehouse

Alexandra Morehouse, CMO of Banner Health

Alexan­dra M. More­house is Senior Vice Pres­i­dent & Chief Mar­ket­ing Offi­cer for Ban­ner Health, one of the nation’s largest non­prof­it health sys­tems. Pri­or to Ban­ner Health, she was the Vice Pres­i­dent of Brand Man­age­ment at Kaiser Per­ma­nente, and CMO of AAA. Ms. More­house has also served as co-chair of the Har­vard Busi­ness School Glob­al Tech­nol­o­gy Con­fer­ence and on the boards of the Har­vard Busi­ness School Com­mu­ni­ty Part­ners, Snap­Fish, Yer­ba Bue­na Cen­ter for the Arts, ODC Dance, and UC Davis. She grad­u­at­ed with high hon­ors from Har­vard Uni­ver­si­ty and has an MBA from Har­vard Busi­ness School.

Dr. Alison Fenney, Executive Director of the Neurotechnology Industry Organization (NIO)

Dr. Fen­ney runs the Neu­rotech­nol­o­gy Indus­try Orga­ni­za­tion, a glob­al trade asso­ci­a­tion rep­re­sent­ing com­pa­nies involved in neu­ro­science, brain research insti­tutes and patient advo­ca­cy groups. Pri­or to NIO, Ali­son was Man­ag­er of Indus­try Rela­tions at the Ontario Brain Insti­tute (OBI) in Cana­da, and also worked in Equi­ty Research at Bloom Bur­ton & Co. She has a PhD in Neu­ro­science and an MBA from McMas­ter Uni­ver­si­ty, a Mas­ters in Neu­ro­ki­net­ics from the Uni­ver­si­ty of Que­bec at Mon­tre­al, and a Bach­e­lor of Kine­si­ol­o­gy (hon­ors) from Brock University.

Álvaro Fernández, CEO and Editor-in-Chief of SharpBrains

Álvaro Fer­nán­dez, a mem­ber of the World Eco­nom­ic Forum’s Coun­cil on the Future of Human Enhance­ment, runs Sharp­Brains, an inde­pen­dent mar­ket research firm track­ing health and per­for­mance appli­ca­tions of brain sci­ence. Mr. Fer­nan­dez is the co-author of “The Sharp­Brains Guide to Brain Fit­ness: How to Opti­mize Brain Health and Per­for­mance at Any Age”, and the Edi­tor-in-chief of Sharp­Brains’ mar­ket report on Per­va­sive Neu­rotech­nol­o­gy. Pre­vi­ous­ly he worked in McK­in­sey & Com­pa­ny, Ber­tels­mann, Docent and Ashoka: Inno­va­tors for the Pub­lic, and has an MBA and MA in Edu­ca­tion from Stan­ford Uni­ver­si­ty and a BA in Eco­nom­ics from Uni­ver­si­dad de Deusto, in his native Spain.

Dr. Álvaro Pascual-Leone, Director of the Berenson-Allen Center for Noninvasive Brain Stimulation at Beth Israel Deaconess Medical Center

Dr. Pas­cual-Leone is a world leader in the devel­op­ment of tran­scra­nial mag­net­ic stim­u­la­tion for appli­ca­tion in cog­ni­tive neu­ro­science and for ther­a­peu­tic appli­ca­tions in neu­rol­o­gy, psy­chi­a­try, and neu­rore­ha­bil­i­ta­tion. He is a Pro­fes­sor of Neu­rol­o­gy and an Asso­ciate Dean for Clin­i­cal and Trans­la­tion­al Research at Har­vard Med­ical School, and serves as Chief for the Divi­sion of Cog­ni­tive Neu­rol­o­gy and the Direc­tor of the Beren­son-Allen Cen­ter for Non­in­va­sive Brain Stim­u­la­tion at Beth Israel Dea­coness Med­ical Cen­ter. Pas­cual-Leone’s research projects aim at under­stand­ing the mech­a­nisms that con­trol brain plas­tic­i­ty across the lifes­pan to be able to mod­i­fy them for the subject’s opti­mal behav­ioral outcome.

Dr. Amy Serin, Co-Founder & Chief Science Officer at The Touchpoint Solution

Dr. Amy Serin, the cur­rent pres­i­dent of the Ari­zona Neu­ropsy­cho­log­i­cal Soci­ety, is Co-Founder & Chief Sci­ence Offi­cer at The Touch­point Solu­tion. She is cred­it­ed with invent­ing BLAST (Bi-Lat­er­al Alter­nat­ing Stim­u­la­tion deliv­ered Tac­tile) tech­nol­o­gy as part of neu­ro­science research and prac­tice at The Serin Cen­ters. Dr. Serin over­sees research part­ner­ships with Uni­ver­si­ties across the globe, and is past Vale­dic­to­ri­an at ASU, Phoenix Young Woman of The Year and Advo­cate of The Year.

Dr. Anna Wexler, science writer, filmmaker and postdoc fellow in advanced biomedical ethics at UPenn

Dr. Anna Wexler is a sci­ence writer, film­mak­er and post­doc fel­low in advanced bio­med­ical ethics at the Depart­ment of Med­ical Ethics & Health Pol­i­cy at the Uni­ver­si­ty of Penn­syl­va­nia. Her research cen­ters on the eth­i­cal, legal and social impli­ca­tions of emerg­ing neu­rotech­nol­o­gy. Dr. Wexler received her Ph.D. in 2017 from the HASTS (His­to­ry, Anthro­pol­o­gy, Sci­ence, Tech­nol­o­gy & Soci­ety) Pro­gram at MIT, where she exam­ined do-it-your­self and direct-to-con­sumer appli­ca­tions of non­in­va­sive brain stim­u­la­tion. She is cur­rent­ly explor­ing the eth­i­cal and reg­u­la­to­ry chal­lenges raised by the full spec­trum of inter­ven­tions used in the home to mod­i­fy brain function.

Dr. April Benasich, Director of the Infancy Studies Laboratory at the Rutgers Center for Molecular and Behavioral Neuroscience

As direc­tor of the Infan­cy Stud­ies Lab­o­ra­to­ry at the Rut­gers Cen­ter for Mol­e­c­u­lar and Behav­ioral Neu­ro­science, Dr. April Benasich’s research focus­es on brain devel­op­ment in infan­cy and ear­ly child­hood, specif­i­cal­ly the neur­al process­es nec­es­sary for nor­mal lan­guage and cog­ni­tive devel­op­ment. She uses a mix of cut­ting-edge tech­nolo­gies, includ­ing mea­sure­ment of audi­to­ry evoked brain poten­tials (EEG/ERPs) and nat­u­ral­ly sleep­ing MRI/fMRI, that add con­verg­ing non­in­va­sive phys­i­o­log­i­cal mea­sures to her lab’s exten­sive behav­ioral battery.

Ariel Garten, Founder and Chief Evangelism Officer at InteraXon

Ariel Garten is the Founder and Chief Evan­ge­lism Offi­cer of Inter­aXon, which cre­ates thought con­trolled com­put­ing prod­ucts and appli­ca­tions. Ariel has also researched at the Krem­bil Neu­ro­science Insti­tute study­ing hip­pocam­pal neu­ro­ge­n­e­sis, dis­played work at the Art Gallery of Ontario, been head design­er at a fash­ion label, and opened Toron­to Fash­ion Week. Referred to as the “Brain Guru” by Now Mag­a­zine, CBC Radio and the Toron­to Star, Ariel has also run a suc­cess­ful real estate busi­ness, spent time as the design­er and own­er of a Cana­dian fash­ion bou­tique, and is a prac­tic­ing psychotherapist.

Belén Guerra-Carrillo, NSF Fellow and graduate student researcher at University of Califonia, Berkeley

Belen Guer­ra-Car­ril­lo was recent­ly award­ed a fel­low­ship by the Nation­al Sci­ence Foun­da­tion for her grad­u­ate research efforts. Her recent achieve­ment earned Guer­ra-Car­ril­lo a spot on The City Uni­ver­si­ty of New York’s new team of award-win­ning “Sci­ence All-Star” stu­dents who have won Nation­al Sci­ence Foun­da­tion (NSF) Grad­u­ate Research Fel­low­ships, the most pres­ti­gious awards a grad­u­ate stu­dent in the STEM dis­ci­plines (sci­ence, tech­nol­o­gy, engi­neer­ing, and math­e­mat­ics) can receive. The awards rec­og­nize and sup­port excep­tion­al stu­dents who have pro­posed grad­u­ate-lev­el research projects in their fields.


Dr. Bill Reichman, President of Baycrest

Dr. Reich­man is Pres­i­dent and Chief Exec­u­tive Offi­cer of Bay­crest, one of the world’s pre­mier aca­d­e­m­ic health sci­ences cen­tres focused on aging and brain func­tion. Dr. Reich­man, an inter­na­tion­al­ly-known expert in geri­atric men­tal health and demen­tia is also Pro­fes­sor of Psy­chi­a­try on the Fac­ul­ty of Med­i­cine at the Uni­ver­si­ty of Toron­to. He is a not­ed author­i­ty on the deliv­ery of men­tal health and demen­tia ser­vices in nurs­ing home set­tings. Dr. Reich­man is a for­mer Pres­i­dent of the Amer­i­can Asso­ci­a­tion for Geri­atric Psy­chi­a­try and the Geri­atric Men­tal Health Foundation.

Bill Tucker, Senior Advisor to the K12 Education Program at the Bill & Melinda Gates Foundation

Bill Tuck­er is the senior advi­sor of K12 Edu­ca­tion Pro­grams at the Bill & Melin­da Gates Foun­da­tion, where he’s respon­si­ble for iden­ti­fy­ing and address­ing crit­i­cal, emerg­ing cross-cut­ting strat­e­gy issues and devel­op­ment of strate­gic part­ner­ships with key stake­hold­ers, grantees, and local, region­al and nation­al fun­ders. Bill is also respon­si­ble for K‑12 advocacy/policy grant­mak­ing port­fo­lio, han­dling a team of six senior pro­gram offi­cers and strate­gic pri­or­i­ti­za­tion, bud­get­ing, and allo­ca­tion of $40+ mil­lion grant­mak­ing port­fo­lio. He holds an MBA and MA in Edu­ca­tion from Stan­ford University.

Robert Bilder

Dr. Bob Bilder, Direc­tor of the UCLA Ten­nen­baum Cen­ter for the Biol­ogy of Creativity

Dr. Bob Bilder is the Direc­tor of the Ten­nen­baum Cen­ter for the Biol­ogy of Cre­ativ­ity in the Jane & Ter­ry Semel Insti­tute for Neu­ro­science and Human Behav­ior, and the Michael E. Ten­nen­baum Fam­ily Pro­fes­sor of Psy­chi­a­try & Biobe­hav­ioral Sci­ences and Chief of Med­ical Psy­chol­ogy — Neu­ropsy­chol­ogy at David Gef­fen School of Med­i­cine. He has received many awards for his research con­tri­bu­tions, served on diverse fed­eral and inter­na­tional advi­sory boards, pro­vided edi­to­r­ial ser­vice to many schol­arly jour­nals, and received mul­ti­ple grants from the NIH, pri­vate foun­da­tions, and industry.

Dr. Bob Schafer, Head of Research at Lumosity

Bob Schafer over­sees Research Sci­ence and Data Sci­ence, com­bin­ing his back­ground in neu­ro­science research and prod­uct devel­op­ment to help trans­late sci­en­tif­ic knowl­edge into prod­ucts for assess­ing and train­ing men­tal per­for­mance. Pri­or to Lumos, Bob was the founder and CEO of Prophe­cy Sci­ences, a start­up using neu­ro­science and pre­dic­tive ana­lyt­ics to improve hir­ing deci­sions and team devel­op­ment. He earned his PhD in neu­ro­science from Stan­ford Uni­ver­si­ty, was a post­doc­tor­al fel­low at MIT and has pub­lished research in jour­nals includ­ing Sci­ence and Neuron.

Charlie Hartwell

Charlie Hartwell, Operating Partner at the Bridge Builders Collaborative

Char­lie helps fund and sup­port the visions of social entre­pre­neurs who have scal­able busi­ness mod­els for appli­ca­tions, prac­tices, prod­ucts, and tools that build bridges for mind-train­ing. He is a Har­vard Busi­ness School grad­u­ate who has led, found­ed, run and worked in orga­ni­za­tions in 16 dif­fer­ent indus­tries. Pre­vi­ous­ly Char­lie was Pres­i­dent of Ideas to Go, an inno­va­tion-con­sult­ing firm. His career has includ­ed Wall Street, cor­po­rate mar­ket­ing stints at HJ Heinz and Pills­bury. In 1998, he formed the first for-prof­it expe­di­tion com­pa­ny in the US, help­ing launch the his­toric Ban­croft Arne­sen Expe­di­tion across Antarc­ti­ca by polar explor­ers Ann Ban­croft and Liv Arnesen.

Colin Milner

Colin Milner, Founder and CEO of the International Council on Active Aging (ICAA)

Col­in Mil­ner is Founder and CEO of ICAA, and a lead­ing author­i­ty on the health and well-being of old­er adults. He has been rec­og­nized by the World Eco­nom­ic Forum as one of “the most inno­v­a­tive and influ­en­tial minds” in the world on aging-relat­ed top­ics. He has been pub­lished thought-lead­er­ship arti­cles in jour­nals such as Glob­al Pol­i­cy, and the Annu­al Review of Geron­tol­ogy and Geri­atrics. Mil­ner’s speech­es have stim­u­lat­ed thou­sands of busi­ness and gov­ern­ment lead­ers, indus­try pro­fes­sion­als, and old­er adults worldwide.

Dr. Corinna Lathan, CEO of AnthroTronix and Co-Chair of the World Economic Forum’s Council on the Future of Human Enhancement

Dr. Corin­na Lath­an is Co-Founder and CEO of Anthro­Tron­ix, Inc., an engi­neer­ing R&D com­pa­ny cre­at­ing diverse human-cen­tered prod­ucts in dig­i­tal health, wear­able tech­nol­o­gy, robot­ics, and aug­ment­ed real­i­ty. Most recent­ly, Dr. Lath­an led the tech­ni­cal team to devel­op DANA, an FDA-cleared, dig­i­tal health soft­ware to eval­u­ate cog­ni­tive func­tion dur­ing treat­ment for depres­sion, brain injury, and post-trau­mat­ic stress. For this work, she was named a 2017 Woman to Watch by Dis­rup­tive Women in Health Care. Dr. Lath­an is cur­rent­ly co-Chair of the World Eco­nom­ic Forum’s Glob­al Future Coun­cil on Human Enhance­ment and is a thought leader on tech­nol­o­gy trends that impact health and healthcare.

Dr. Chris Walling, Chairman of the Education Advisory Committee for the Alzheimer’s Research and Prevention Foundation

Chris Walling, PsyD, MBA, C‑IAYT has been an active leader in health­care for near­ly two decades. His work inte­grates the devel­op­men­tal, bio­log­i­cal, and somat­ic aspects of the lifes­pan. His work in aca­d­e­m­ic med­i­cine has includ­ed the admin­is­tra­tion of mul­ti­dis­ci­pli­nary lead­er­ship teams in hema­tol­ogy-oncol­o­gy, phys­i­cal med­i­cine and reha­bil­i­ta­tion, and geri­atric psy­chi­a­try. He cur­rent­ly serves as Chair­man of the Edu­ca­tion Advi­so­ry Com­mit­tee for the Alzheimer’s Research and Pre­ven­tion Foun­da­tion, and is also the Pres­i­dent of the Unit­ed States Asso­ci­a­tion of Body Psy­chother­a­py. His clin­i­cal focus in the behav­ioral sci­ences has exam­ined the inter­sec­tions of neu­ropsy­chother­a­py, affect reg­u­la­tion, and body psychology.


Danny Dankner, CEO of Applied Cognitive Engineering (ACE)

Dan­ny runs Applied Cog­ni­tive Engi­neer­ing (ACE), a cog­ni­tive sim­u­la­tions firm that devel­ops spe­cial­ized “brain gyms” to enhance the per­for­mance in high-pres­sure domains. Pre­vi­ous­ly he was on the found­ing team of Kinet­i­ca Inter­net­ting Solu­tions, direct­ed the Project Man­age­ment activ­i­ties at Mobile­S­pear, and had a key role in the merg­er of G‑sites and Box Inter­ac­tive, lead­ing to the cre­ation of Scepia Inter­net Solu­tions — Israel’s largest solu­tion provider. Dan­ny holds an MBA in Mar­ket­ing & IT and LL.B, both from Tel Aviv Uni­ver­si­ty and an Israeli Bar Diplo­ma. He is a cer­ti­fied sys­tem analyst.

Dr. David Bach, Founder & President of the Platypus Institute

Dr. David Bach is a Har­vard-trained sci­en­tist, physi­cian, and ser­i­al entre­pre­neur. After spend­ing a decade max­i­miz­ing his phys­i­cal and men­tal per­for­mance, he cre­at­ed the Platy­pus Insti­tute to bring sci­en­tif­ic rig­or to, and cre­ate com­mer­cial appli­ca­tions in, the rapid­ly expand­ing are­na of applied neu­ro­science. As a busi­ness entre­pre­neur, David found­ed and built three health­care com­pa­nies, each of which became a $100M enter­prise. He has also been a man­age­ment con­sul­tant, a ven­ture cap­i­tal­ist, a com­pet­i­tive mar­tial artist, and a pro­fes­sion­al cel­list. Dr. Bach has always had a pas­sion­ate inter­est in human development.


Dr. David Barash, Chief Medical Officer and Executive Director of Global Health at GE Foundation

David M. Barash, M.D. is the ED of the Glob­al Health Port­fo­lio and Chief Med­ical Offi­cer for the GE Foun­da­tion, where ini­tia­tives are approached with the belief that sim­ple inter­ven­tions, along with strong part­ner­ships and lead­ers, are often the answer to some of the healthcare’s most com­plex prob­lems. He is also co-chair of the Pri­vate Sec­tor Round­table, a col­lab­o­ra­tion of sev­er­al multi­na­tion­al com­pa­nies to sup­port the work of the Glob­al Health Secu­ri­ty Agen­da.  Dr. Barash is a prac­tic­ing emer­gency med­i­cine physi­cian with more than 30 years’ expe­ri­ence and great inter­est on under­stand­ing how new tech­nolo­gies can be com­mer­cial­ized and deliv­ered to effec­tive­ly close the gap between brain­storm and bedside.

Dr. David Bartrés-Faz, Principal Investigator of the Barcelona Brain Health Initiative (BBHI)

David Bartrés-Faz is the Prin­ci­pal Inves­ti­ga­tor of the Barcelona Brain Health Ini­tia­tive study, a prospec­tive lon­gi­tu­di­nal cohort inves­ti­ga­tion deb­it­ed to study the pro­tec­tive fac­tors as well as the asso­ci­at­ed brain mech­a­nisms that explain resilience to dis­ease and main­te­nance of cog­ni­tive func­tion with advanc­ing age. He is also the PI of the Barcelona group with­in the H2020 ‘Lifebrain’ project as well as of a Nation­al research study fund­ed by the Span­ish Min­istry to inves­ti­gate the puta­tive syn­er­gic effects of non-inva­sive brain stim­u­la­tion in com­bi­na­tion with cog­ni­tive train­ing in Mild Cog­ni­tive Impair­ment patients. He is also respon­si­ble for the Barcelona Brain Stim­u­la­tion Lab at the Uni­ver­si­ty of Barcelona.

David Klein, Co-Founder & CEO of Click Therapeutics

David is a health­care investor and entre­pre­neur with over 15 years life sci­ence indus­try expe­ri­ence; he has played key roles in found­ing, financ­ing and devel­op­ing more than 10 life sci­ence com­pa­nies. In 2012, David co-found­ed Click Ther­a­peu­tics which focus­es on engi­neer­ing, val­i­dat­ing and com­mer­cial­iz­ing Dig­i­tal Ther­a­peu­tic­sTM solu­tions to ben­e­fit peo­ple with unmet needs through cog­ni­tive and neu­robe­hav­ioral mod­i­fi­ca­tion. He for­mer­ly served as Man­ag­ing Direc­tor at a life sci­ence asset man­age­ment firm, senior con­sul­tant to Pfiz­er, and strate­gic advi­sor to numer­ous pub­licly trad­ed and pri­vate­ly held life sci­ence companies.

Debra Gilmore, Exec­u­tive Director of The Arrow­smith Program

Deb­bie Gilmore is the new Exec­u­tive Direc­tor of Arrow­smith Pro­gram, hav­ing been Arrowsmith’s rep­re­sen­ta­tive in Aus­tralia and New Zealand for 18 months. Deb­bie first heard about the Arrow­smith Pro­gram when she was Head of Diverse Learn­ing Needs at the Catholic Edu­ca­tion Office, Syd­ney, Aus­tralia. Her work as a teacher, lit­er­a­cy advis­er, assis­tant prin­ci­pal and prin­ci­pal helped her under­stand the need to ‘unlock’ the poten­tial of stu­dents with learn­ing dif­fi­cul­ties, and her role as a moth­er of a son with such chal­lenges gave her first hand expe­ri­ence of their strug­gles. Deb­bie holds a Mas­ters of Edu­ca­tion and var­i­ous Grad­u­ate Cer­tifi­cates in Education.

Dr. Eddie Martucci, CEO of Akili Interactive Labs

Dr. Mar­tuc­ci is co-founder and CEO at Akili Inter­ac­tive Labs, a dig­i­tal health com­pa­ny aim­ing to make the first reg­u­la­to­ry-approved diag­nos­tic and ther­a­peu­tic video games. He spear­head­ed the clin­i­cal part­ner­ships that Akili now has with Pfiz­er and mul­ti­ple top-tier aca­d­e­m­ic insti­tu­tions. Dr. Mar­tuc­ci is also a Prin­ci­pal at PureTech Ven­tures. He was pre­vi­ous­ly a Kauff­man Entre­pre­neur Fel­low. Dr. Mar­tuc­ci com­plet­ed his grad­u­ate work at Yale Uni­ver­si­ty in the Depart­ments of Phar­ma­col­o­gy and Mol­e­c­u­lar Bio­physics & Bio­chem­istry, and received a BS in Bio­chem­istry from Prov­i­dence Col­lege and a PhD and MPhil from Yale University.

Eduardo Briceño, CEO of Mind­set Works

Eduar­do is the Co-Founder and CEO of Mind­set Works, which he start­ed with Car­ol Dweck, Lisa Black­well and oth­ers, to help peo­ple devel­op as moti­vat­ed and effec­tive learn­ers. Pri­or to Mind­set Works, Eduar­do was an Edu­ca­tion Pio­neers Fel­low at New Lead­ers, a Prin­ci­pal with the Sprout Group,and an ana­lyst with Don­ald­son, Lufkin & Jen­rette. Eduar­do holds MBA and M.A. in Edu­ca­tion degrees from Stan­ford Uni­ver­si­ty, and bachelor’s degrees in Eco­nom­ics and in Engi­neer­ing from the Uni­ver­si­ty of Pennsylvania.

Edward Kliphuis, Investment Director of Merck Ventures

Edward Kli­phuis, Invest­ment Direc­tor at Mer­ck Ven­tures and Board Observ­er at Akili Inter­ac­tive Labs, looks for new invest­ment oppor­tu­ni­ties for the 300 mil­lion euro Mer­ck Ven­tures fund. Pre­vi­ous­ly he was at Kem­pen & Co, a pan Euro­pean mer­chant bank head­quar­tered in Ams­ter­dam, the Nether­lands, where he worked in the Life Sci­ences Secu­ri­ties team. Edward was instru­men­tal in the team’s con­tin­u­ous fundrais­ing efforts for list­ed Euro­pean small and mid-cap biotech com­pa­nies in over 20 deals. He holds an M.Sc. degree in Bio­phar­ma­ceu­ti­cal Sci­ences from Lei­den Uni­ver­si­ty, the Nether­lands, with spe­cial­iza­tions in phar­ma­col­o­gy and sci­ence-based business.

Dr. Graeme Moffat, Direc­tor of Sci­en­tific & Reg­u­la­tory Affairs at InteraXon

Graeme leads health and neu­ro­science R&D at Inter­aX­on, the mak­er of Muse: the brain sens­ing head­band. Pri­or to join­ing Inter­aX­on, he served as Man­ag­ing Edi­tor of the Fron­tiers jour­nal series under the Nature Pub­lish­ing Group, cov­er­ing Neu­ro­science, Neu­rol­o­gy, and Psy­chi­a­try. Grae­me’s expe­ri­ence includes research engi­neer­ing with CNRS (France) and Neurelec/Oticon Med­ical on hear­ing aids and cochlear implants, as well as clin­i­cal tri­al devel­op­ment. He holds a PhD in neu­ro­science from Uni­ver­sité Aix-Mar­seille and a BSc in physics from McMas­ter Uni­ver­si­ty and is cur­rent­ly a fel­low of the Ontario Cen­tres of Excel­lence in Toronto.

Greg Wong, VP Product Management at Savonix

Mr. Gre­go­ry Wong is a mul­ti­dis­ci­pli­nary entre­pre­neur. He has held lead­er­ship posi­tions in pre­dic­tive ana­lyt­ics, med­ical device, and com­mu­ni­ty health cen­ters. As pub­lished author in radi­ol­o­gy and as an award-win­ning pre­sen­ter on research in mind-body med­i­cine, Mr. Wong found his way to Savonix with a con­ver­sa­tion with Dr. Char­vat around the impor­tance of cog­ni­tion in health care. Lead­ing the prod­uct dri­ve, he is firm believ­er that every­one can ben­e­fit from know­ing this miss­ing vital.

Ignacio de Ramon, Co-Founder & CEO of Sincrolab

Igna­cio de Ramón is a Neu­ropsy­chol­o­gist. PhD Stu­dent in Cog­ni­tive Neu­ro­science and Exec­u­tive MBA by IESE Busi­ness School. He has worked for more than 10 years with patients with Neu­rode­vel­op­men­tal Dis­or­ders in Spe­cial­ized Cen­ters and as a vol­un­teer in dif­fer­ent asso­ci­a­tions. He is a Pro­fes­sor of Neu­ropsy­cho­log­i­cal Eval­u­a­tion in two Span­ish Uni­ver­si­ties and of Entre­pre­neur­ship in Indus­tri­al Orga­ni­za­tion School.

Jafar Sabbah, Founder & CEO of Beam Riders

Jafar Sab­bah is a sea­soned tech­nol­o­gy and social entre­pre­neur with more than 20 years of expe­ri­ence. Jafar is the Founder & CEO of Beam Rid­ers, a start­up buil­ing a cloud-base track­ing sys­tem to mon­i­tor cog­ni­tive skills using EEG and behav­iour­al attrib­ut­es data. Before that he worked in the fields of inter­net, bio­med­ical tech­nol­o­gy, micro-finance, and eco­nom­ic devel­op­ment in addi­tion to a suc­cess­ful legal prac­tice. Jafar has been quot­ed in lead­ing news­pa­pers and arti­cles around the globe, and is a mem­ber of the sec­ond class of the Mid­dle East Lead­er­ship Ini­tia­tive of The Aspen Insti­tute and a Fel­low of the Aspen Glob­al Lead­er­ship Network.

Jan Samzelius, Co-Founder & CEO

Jan has spe­cial­ized in quan­ti­ta­tive meth­ods for 40 years and has invent­ed the typ­ing cadence tech­nol­o­gy cen­tral to Neu­raMetrix. He has pre­vi­ous­ly led a large num­ber of ana­lyt­i­cal projects, rang­ing from mea­sur­ing cus­tomer sat­is­fac­tion to price elas­tic­i­ties to con­joint analy­ses. He has been the CEO of six com­pa­nies (most of them star­tups), in sev­er­al cas­es improv­ing prof­its dra­mat­i­cal­ly. His expe­ri­ence includes one turn­around and one suc­cess­ful exit. Jan holds a BSc in eco­nom­ics from the Stock­holm School of Eco­nom­ics, grad­u­at­ing with hon­ors and an MBA from Har­vard Busi­ness School.

Karen Postal

Dr. Karen Postal, President of the American Academy of Clinical Neuropsychology (AACN)

Dr. Postal is a board cer­ti­fied in neu­ropsy­chol­o­gy and pedi­atric neu­ropsy­chol­o­gy, and a clin­i­cal instruc­tor at Har­vard Med­ical School, where she teach­es post­doc­tor­al fel­lows in neu­ropsy­chol­o­gy. She also works with stu­dents from ele­men­tary school through col­lege to over­come bar­ri­ers to aca­d­e­m­ic suc­cess. Dr. Postal has an exper­tise in work­ing with trau­mat­ic brain injury and has been des­ig­nat­ed a neu­tral neu­ropsy­chol­o­gist for the Nation­al Foot­ball League. She is the author of Feed­back that Sticks: The Art of Effec­tive­ly Com­mu­ni­cat­ing Neu­ropsy­cho­log­i­cal Assess­ment Results.

Kathleen Herath

Kathleen Herath, Associate Vice President Health & Productivity at Nationwide Insurance

Kath­leen Herath over­sees the Health and Pro­duc­tiv­i­ty strat­e­gy at Nation­wide for the company’s 33,000 asso­ciates. She is respon­si­ble for the company’s inte­grat­ed health and pro­duc­tiv­i­ty pro­gram, which includes: health screen­ings, well­ness pro­grams, dis­abil­i­ty and dis­ease man­age­ment, health edu­ca­tion, work-life resources and walk­ing pro­grams and occu­pa­tion­al health clin­ics. The Health and Pro­duc­tiv­i­ty pro­gram at Nation­wide has received numer­ous nation­al awards for the first four years includ­ing the 2009 IBI Health Inno­va­tion Award, the Amer­i­can Heart Association’s Plat­inum Fit-Friend­ly Employ­er award, the 2010 HUB mag­a­zine APEX award and the pres­ti­gious C. Everett Koop Nation­al Health Award.

Kayt Sukel, science writer

Kayt Sukel is pas­sion­ate sci­ence writer who has no prob­lem tack­ling inter­est­ing (and often taboo) sub­jects span­ning love, sex, tech­nol­o­gy, and the brain. Her work has appeared in the Atlantic Month­ly, New Sci­en­tist, For­tune, Pacif­ic Stan­dard, and the Wash­ing­ton Post, just to name a few. She is the author of the books Dirty Minds: How Our Brains Influ­ence Love, Sex, and Rela­tion­ships (reti­tled as This Is Your Brain on Sex: The Sci­ence Behind the Search for Love in paper­back) and The Art of Risk: The New Sci­ence of Courage, Cau­tion, and Chance – and is cur­rent­ly at work on a book about neuroenhancement.

Leanne Young, Executive Director of the new Brain Performance Institute at UT-Dallas Center for BrainHealth

After more than 20 years in engi­neer­ing, Leanne Young joined the Cen­ter for Brain­Health to lead its Brain Per­for­mance Insti­tute. Pri­or to join­ing the Brain Per­for­mance Insti­tute, Leanne ran a divi­sion of Applied Research Asso­ciates, help­ing estab­lish human vul­ner­a­bil­i­ty as a core busi­ness area for the firm. She is a nation­al­ly rec­og­nized expert in blast injury research and worked with the Depart­ment of Defense’s Com­bat­ing Ter­ror­ism Tech­nol­o­gy Sup­port Office to obtain the first his­to­log­i­cal evi­dence of pri­ma­ry blast-induced brain injuries. She also worked with DARPA to lead the first clin­i­cal tri­als of blast-induced brain injuries and, work­ing with the Office of Naval Research, she led devel­op­ment of a com­put­er mod­el for plan­ning the med­ical response to a blast attack on a ship.

Dr. Lew Lim, CEO & Founder of VieLight

Lew Lim is an engi­neer with a pas­sion for help­ing peo­ple. He is the co-inven­tor of sev­er­al wear­able pho­to­bio­mod­u­la­tion (PBM) / low lev­el light ther­a­py devices, and has been rec­og­nized for the devel­op­ment of the intranasal light ther­a­py sys­tems, par­tic­u­lar­ly to address neu­ro­log­i­cal issues. He is a Doc­tor of Nat­ur­al Med­i­cine with addi­tion­al diplo­mas in Med­ical Neu­ro­science and Busi­ness and Accoun­tan­cy. He obtained his degrees and diplo­mas from the Uni­ver­si­ty of Cal­i­for­nia at Berke­ley, Uni­ver­si­ty of Sheffield, Duke Uni­ver­si­ty, Quan­tum Uni­ver­si­ty and The Char­tered Insti­tute of Man­age­ment Accoun­tants, UK.

Lisa Neuberger, Managing Director of Strategy + Innovation at Accenture Corporate Citizenship

Lisa Neu­berg­er leads a glob­al team to define strate­gic direc­tion in areas such as social inno­va­tion, envi­ron­men­tal sus­tain­abil­i­ty and non-finan­cial trans­paren­cy. A social intrapre­neur, she has a 19-year track record at Accen­ture man­ag­ing teams to launch inno­v­a­tive ini­tia­tives such as AI4Good, new busi­ness lines in Sus­tain­abil­i­ty and Pub­lic Ser­vice Val­ue, a glob­al Eco Cham­pi­on pro­gram for employ­ees, and a non­prof­it con­sult­ing orga­ni­za­tion. She has also worked at the White House, the OECD, and CBS News—and holds grad­u­ate degrees from Whar­ton Busi­ness School and the Fletch­er School of Law and Diplo­ma­cy at Tufts University.

Martina Ratto, Cognitive Scientist at MyCognition

Mar­ti­na Rat­to works at the Lon­don-based com­pa­ny MyCog­ni­tion Ltd as a cog­ni­tive sci­en­tist, inves­ti­gat­ing the poten­tial of cog­ni­tive assess­ment and train­ing pro­grammes in dif­fer­ent clin­i­cal and real-world set­tings, and edu­cat­ing peo­ple in under­stand­ing how cog­ni­tion works. She is also co-author of the award-win­ner paper “The Use of an IT-based Cog­ni­tive Assess­ment and Train­ing as a part of a Smart City Pro­gram” pre­sent­ed at The Eleventh Inter­na­tion­al Con­fer­ence on Dig­i­tal Soci­ety and eGov­ern­ments. Mar­ti­na obtained a BA and MA degree from the Uni­ver­si­ty of Genoa, focus­ing on the the­o­ret­i­cal foun­da­tions of cog­ni­tive sci­ence and the real-world appli­ca­tions of cog­ni­tive psy­chol­o­gy and intel­li­gent sys­tems theories.


Nancy Briefs, President and CEO of Digital Cognition Technologies

Ms. Briefs’ is a ser­i­al entre­pre­neur, hav­ing helped suc­cess­ful­ly devel­op and com­mer­cial­ize inno­v­a­tive tech­nolo­gies with six med-tech star­tups. In July 2017, Ms. Briefs was appoint­ed CEO & Pres­i­dent of Dig­i­tal Cog­ni­tion Tech­nolo­gies (DCT), found­ed to mar­ket easy to admin­is­ter and non-inva­sive tests to detect presymp­to­matic cog­ni­tive impair­ment. Pri­or to her work at DCT, Nan­cy Co-Found­ed and was the CEO of Info­Bion­ic, a lead­ing dig­i­tal health plat­form for detec­tion of car­diac arrhyth­mias. Hav­ing raised over $300M in ven­ture cap­i­tal and four suc­cess­ful liq­uid­i­ty events, she has proven the abil­i­ty to lead teams from con­cept thru com­mer­cial­iza­tion and val­ue creation.


Neil Allison, Director of Business Model Innovation at Pearson North America

Neil is the direc­tor of Busi­ness Mod­el Inno­va­tion at Pear­son North Amer­i­ca. Hav­ing Thir­teen years of expe­ri­ence suc­cess­ful­ly build­ing new mar­kets for dig­i­tal prod­ucts and ser­vices. Neil has hands-on exper­tise across the ecosys­tem of edu­ca­tion tech­nol­o­gy (learn­ing and col­lab­o­ra­tion man­age­ment, out­comes assess­ment, tutor­ing, dig­i­tal con­tent, and con­tent dis­tri­b­u­tion). His spe­cial­ties include Busi­ness strat­e­gy and plan­ning, new prod­uct strat­e­gy and devel­op­ment, cus­tomer and mar­ket devel­op­ment, strate­gic mar­ket­ing, pro­gram strat­e­gy and design, high­er edu­ca­tion innovation.

Nikhil Sri­ra­man, IP Analyst at SharpBrains

Nikhil Sri­ra­man is a patent attor­ney admit­ted to prac­tice before the Unit­ed States Patent and Trade­mark Office (USPTO). Nikhil has held posi­tions at the USPTO, IP law firms and in-house at For­tune 500 com­pa­nies. He cur­rently serves as eBay’s Intel­lec­tual Prop­erty Strate­gist, as well as Sharp­Brains’ IP Ana­lyst. With degrees by DePaul Uni­ver­si­ty Col­lege of Law and the Uni­ver­si­ty of Michi­gan, Nikhil’s pro­fes­sion­al expe­ri­ence includes legal and engi­neer­ing work at Ford and John­son Controls.

Dr. Oliver Harrison, Chief Executive of the Health Moonshot at Telefónica Innovation

Dr. Oliv­er Har­ri­son, a mem­ber of the World Eco­nom­ic Forum’s Coun­cil on the Future of Human Enhance­ment, runs an ambi­tious Health Moon­shot at Tele­fóni­ca Inno­va­tion. Pri­or to Tele­fóni­ca, Dr. Har­ri­son was a Senior Vice Pres­i­dent with Health­ways Inter­na­tion­al, a Con­sul­tant to the World Health Organ­i­sa­tion on mHealth for tack­ling Non-Com­mu­ni­ca­ble Dis­eases, and the Direc­tor of Strat­e­gy at the Health Author­i­ty-Abu Dhabi, where he helped dri­ve a com­pre­hen­sive reform of Abu Dhabi’s health sys­tem. Dr. Har­ri­son spent five years with McK­in­sey health­care prac­tice and is a physi­cian with US Nation­al Board Cer­ti­fi­ca­tion in Pub­lic Health, and Mas­ters’ degrees in Pub­lic Health from Johns Hop­kins and Neu­ro­science from Cam­bridge University.

Olivier Oullier

Dr. Olivier Oullier, President of EMOTIV

Olivi­er Oul­li­er, PhD, is a neu­ro­sci­en­tist, strate­gist, and con­trib­u­tor to For­tune Mag­a­zine, He is the for­mer Head of Strat­e­gy in Glob­al Health and Health­care and Mem­ber of the Exec­u­tive Com­mit­tee of the World Eco­nom­ic Forum, where he was in charge of an inter­na­tion­al project on val­ue-based care involv­ing more than 50 glob­al com­pa­nies and orga­ni­za­tions. Olivi­er is a Full Pro­fes­sor of Behav­ioral and Brain Sci­ences at Aix-Mar­seille Uni­ver­si­ty and taught at the Uni­ver­si­ties of Oxford and Geneva’s exec­u­tive edu­ca­tion pro­grams. His lab and applied research focus on con­sumer behav­ior, engage­ment, influ­ence, social coor­di­na­tion dynam­ics, deci­sion neuroscience.

Paul Lefrere, Innovation Lead at WEKIT — Wearable Experience for Knowledge Intensive Training

Dr. Paul Lefrere is the inno­va­tion lead of WEKIT. Pre­vi­ous­ly, in such roles as Exec­u­tive Direc­tor of eLearn­ing for Microsoft in EMEA, he bal­anced Inno­va­tion, Exe­cu­tion and GoToMar­ket strate­gies, help­ing R&D evolve into win­ning prod­ucts and ser­vices. As a PI/ co-PI/ advi­sor to mul­ti­ple uni­ver­si­ties world­wide, he has led high-impact pub­lic-pri­vate sec­tor projects involv­ing Inno­va­tion, Change Man­age­ment, Knowl­edge Man­age­ment, Tech­nol­o­gy Man­age­ment, Vir­tu­al Sci­ence Parks, Knowl­edge Media, IoT, Blockchain & Privacy.

Dr. Peter Reiner, Co-Founder of the National Core for Neu­roethics at the Uni­ver­sity of British Columbia

Dr. Reiner’s cur­rent focus lies in Tech­nolo­gies of the Extend­ed Mind and in the area of neu­roethics, spe­cial­iz­ing in the non-med­ical impact of tech­nol­ogy on the brain, with par­tic­u­lar inter­ests in the neu­roethics of cog­ni­tive enhance­ment as well as the impact of mod­ern tech­no­log­i­cal soci­ety upon brain func­tion. Dr. Rein­er has a dis­tin­guished track record as a bench research sci­en­tist study­ing the neu­ro­bi­ol­ogy of behav­ioural states and neu­rode­gen­er­a­tive dis­ease, and also was the Pres­i­dent & CEO of Active Pass Phar­ma­ceu­ti­cals, a drug dis­cov­ery com­pany that he found­ed to tack­le the scourge of Alzheimer’s disease.

Dr. Randal Koene, Lead Scientist at Kernel

Dr. Ran­dal Koene is the Lead Sci­en­tist at Ker­nel, a $100-mil­lion-fund­ed start-up build­ing advanced neur­al inter­faces to treat dis­ease and dys­func­tion, illu­mi­nate the mech­a­nisms of intel­li­gence, and extend cog­ni­tion. A neu­ro­sci­en­tist and neu­ro­engi­neer, Dr. Koene also heads, a non­prof­it organ­i­sa­tion try­ing to reverse engi­neer neur­al tis­sue and com­plete brains, and acts as Sci­ence Direc­tor of the 2045 Ini­tia­tive. Pre­vi­ous­ly, he was Direc­tor of Analy­sis at Hal­cy­on Mol­e­c­u­lar and Direc­tor of the Depart­ment of Neu­ro­engi­neer­ing at Tec­na­lia, the third largest pri­vate research orga­ni­za­tion in Europe.

Dr. Ryan D’Arcy, President & Chief Scientific Officer of HealthTech Connex

Hon­oured as a Kick­ass Cana­di­an, Dr Ryan D’Arcy co-found­ed HealthTech Con­nex in 2013 & serves as Pres­i­dent & Chief Sci­en­tif­ic Offi­cer. Dr. D’Arcy is wide­ly acknowl­edged as one of Canada’s lead­ing neu­rotech inno­va­tors, with +200 pub­li­ca­tions, $80M in fund­ing invest­ment for healthtech & sev­er­al break­through biotech­nol­o­gy prod­ucts to mar­ket. He holds full professorship/endowed chair at Simon Fras­er Uni­ver­si­ty, heads Sur­rey Memo­r­i­al Hospital’s Health Sci­ences & Inno­va­tion & serves on numer­ous boards.


Sarah Lenz Lock, Senior Vice President for Policy at AARP and Executive Director of the Global Council on Brain Health (GCBH)

Sarah Lenz Lock is Senior Vice Pres­i­dent for Pol­i­cy in AARP’s Pol­i­cy, Research and Inter­na­tion­al Affairs (PRI), where she helps posi­tion AARP as a thought leader address­ing the major issues fac­ing old­er Amer­i­cans. She leads AARP’s pol­i­cy ini­tia­tives on brain health and care for peo­ple liv­ing with demen­tia, includ­ing serv­ing as the Exec­u­tive Direc­tor of the Glob­al Coun­cil on Brain Health, an inde­pen­dent col­lab­o­ra­tive of sci­en­tists, doc­tors and pol­i­cy experts con­vened by AARP to pro­vide trust­ed infor­ma­tion on brain health. Pri­or to join­ing AARP, she served as a Tri­al Attor­ney for the U.S. Depart­ment of Jus­tice, han­dling com­plex lit­i­ga­tion against fed­er­al agen­cies such as NIH, FDA, the Air Force and Army, and EPA.

Simone Schurle

Dr. Simone Schurle, Assistant Professor for Responsive Biomedical Systems at the Swiss Federal Institute of Technology

Dr. Schurle,  a mem­ber of the World Eco­nom­ic Forum’s Coun­cil on the Future of Human Enhance­ment, is research­ing at the fron­tier of bio­med­ical engi­neer­ing. She grad­u­at­ed from the Karl­sruhe Insti­tute of Tech­nol­o­gy in Indus­tri­al Engi­neer­ing and Man­age­ment with spe­cial­iza­tion in micro/nanosystems, and then joined the Insti­tute of Robot­ics and Intel­li­gent Sys­tems at the Swiss Fed­er­al Insti­tute of Tech­nol­o­gy in Zurich, where she focused on mag­net­ic manip­u­la­tion tech­niques for bio­med­ical appli­ca­tions. She was award­ed with the ETH medal for her doc­tor­al the­sis and with fel­low­ships from the SNSF, DAAD and the Soci­ety in Sci­ence – The Bran­co Weiss fel­low­ship for her post­doc­tor­al stud­ies. She is also co-founder of Mag­nebotiX, a spin-off from ETHZ.

Tara Thiagarajan, Founder and Chief Scientist at Sapien Labs

Tara’s inter­est lies in under­stand­ing large-scale human sys­tems and has worked on new ana­lyt­i­cal approach­es to brain sig­nals (LFP, ECoG and EEG) for over a decade. She has a BA in Math­e­mat­ics from Bran­deis Uni­ver­si­ty, an MBA from the Kel­logg School of Man­age­ment at North­west­ern„ and a Ph.D. in Neu­ro­science from Stan­ford Uni­ver­si­ty. She did her post­doc­tor­al research in neur­al net­work behav­iour at the Sec­tion for Crit­i­cal Brain Dynam­ics at the NIH and is a vis­it­ing sci­en­tist at Nation­al Cen­tre for Bio­log­i­cal Sci­ences.. She is also an Advi­so­ry Group Mem­ber at Ashoka Changemakers.

Thomas R. Insel, MD, President and Co-Founder of Mindstrong Health

Dr. Insel  is a psy­chi­a­trist, neu­ro­sci­en­tist, and cur­rent­ly a co-founder and Pres­i­dent of Mind­strong Health. From 2002–2015, Dr. Insel served as Direc­tor of the Nation­al Insti­tute of Men­tal Health (NIMH), the com­po­nent of the Nation­al Insti­tutes of Health (NIH) com­mit­ted to research on men­tal dis­or­ders. Pri­or to serv­ing as NIMH Direc­tor, Dr. lnsel was Pro­fes­sor of Psy­chi­a­try at Emory Uni­ver­si­ty where he was found­ing direc­tor of the Cen­ter for Behav­ioral Neu­ro­science in Atlanta. Most recent­ly (2015 – 2017), he led the Men­tal Health Team at Ver­i­ly (for­mer­ly Google Life Sci­ences) in South San Fran­cis­co, CA. Dr. Insel is a mem­ber of the Nation­al Acad­e­my of Med­i­cine and has received numer­ous nation­al and inter­na­tion­al awards includ­ing hon­orary degrees in the U.S. and Europe.

Dr. Walter Greenleaf, Medical VR/ AR Expert at Stanford Virtual Human Interaction Lab

Wal­ter is a research sci­en­tist, entre­pre­neur, and med­ical prod­uct devel­op­er, known as an ear­ly pio­neer in the med­ical appli­ca­tion of vir­tu­al envi­ron­ment tech­nol­o­gy and viewed as one of the founders of the field. He has served as CEO and founder for InWorld Solu­tions, spe­cial­iz­ing in the ther­a­peu­tic use of vir­tu­al worlds for behav­ioral health care, and Vir­tu­al­ly Bet­ter, devel­op­ing vir­tu­al envi­ron­ments for the treat­ment of pho­bias, anx­i­ety dis­or­ders, and PTSD. He is Chief Sci­ence Offi­cer for Pear Ther­a­peu­tics and a found­ing Board Mem­ber of the Inter­na­tion­al Soci­ety for Vir­tu­al Reha­bil­i­ta­tion. Wal­ter has also served as a sci­en­tif­ic advis­er and review­er for the U.S. Pub­lic Health Ser­vice, Nation­al Sci­ence Foun­da­tion (NSF), Nation­al Insti­tutes of Health (NIH), NASA, and the U.S. Depart­ment of Education.

Zack Lynch, General Partner at JAZZ Venture Partners

Zack Lynch is an entre­pre­neur, mar­ket maven and futur­ist who brings a rich under­stand­ing of the tech­nolo­gies and com­pa­nies dri­ving the expe­ri­en­tial tech­nol­o­gy mar­ket to JAZZ. He is also the founder and Chair­man of the Neu­rotech­nol­o­gy Indus­try Orga­ni­za­tion, and serves on the advi­so­ry boards of the McGov­ern Insti­tute for Brain Research at MIT, Cen­ter for Neu­roe­co­nom­ic Stud­ies at Clare­mont Grad­u­ate Uni­ver­si­ty, the Cen­ter for Neu­ro­science and Soci­ety at the Uni­ver­si­ty of Penn­syl­va­nia, as well as sev­er­al pri­vate neu­rosoft­ware companies.


–> Learn more & Reg­is­ter for the 2017 Sharp­Brains Vir­tu­al Sum­mit: Brain Enhance­ment in the Dig­i­tal Age (Decem­ber 5–7th).